Results 271 to 280 of about 46,388,210 (340)

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

open access: yesMolecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute   +4 more
wiley   +1 more source

Quantifying urban and landfill methane emissions in the United States using TROPOMI satellite data. [PDF]

open access: yesSci Adv
Wang X   +10 more
europepmc   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

open access: yesMolecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric   +10 more
wiley   +1 more source

From QI-disability to QID-12: creating a brief proxy-report measure of quality of life for children with intellectual disability. [PDF]

open access: yesQual Life Res
Licari MK   +12 more
europepmc   +1 more source

Return to Sports and Clinical Outcomes After Medial Ulnar Collateral Ligament Reconstruction With Semitendinosus Allograft in Overhead Athletes: A Retrospective Case Series. [PDF]

open access: yesOrthop J Sports Med
Moews LD   +9 more
europepmc   +1 more source

Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial. [PDF]

open access: yesEur Heart J
Jais P   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy